Erysipeloid rash: A rare adverse event induced by gemcitabine.

Abstract

Some rare cases of erysipelas-like or pseudocellulitis have been reported in relation to gemcitabine. This rare adverse event is more frequent in the presence of edema. Here, we report a case of pseudocellulitis after adjuvant treatment for pancreatic cancer. Oncologists should be aware of this infrequent and non-well understood adverse event. They should be especially careful when administering gemcitabine in the presence of lymphedema.

• Authors: Ana Ruiz-Casado, David Gutiérrez, Ignacio Juez
• Journal: Journal of cancer research and therapeutics (J Cancer Res Ther) 2015 Oct-Dec Vol. 11 Issue 4 Pg. 1024 ISSN: 1998-4138 [Electronic] India
• PMID: 26881588 (Publication Type: Case Reports, Letter)

Chemical References

• Deoxycytidine
• Gemcitabine

Topics

• Adenocarcinoma (drug therapy, pathology)
• Adult
• Deoxycytidine (adverse effects, analogs & derivatives)
• Erysipeloid (chemically induced, pathology)
• Exanthema (chemically induced, pathology)
• Female
• Humans
• Pancreatic Neoplasms (drug therapy, pathology)
• Prognosis
• Rare Diseases (chemically induced, pathology)
• Gemcitabine